What is I3LUNG
I3LUNG is a European project funded under the framework of the Horizon Europe (HEurope) call “Ensuring access to innovative, sustainable and high-quality health care”. Our consortium gathers 16 partners with different expertise located worldwide, with the common goal of providing better assistance and individualize treatment for patients affected by metastatic lung cancer.
For Patients
In the video below the project explained by Anne-Marie Baird, President of Lung Cancer Europe (LuCE) (one of the partners of the I3LUNG).
“We are excited to start this project which is envisioned to both generate novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools in the European industry. (I3LUNG Partners)„
Find out the most relevant news on the latest advancements in lung cancer!
News
May, 6 2026
We’re taking over the ESAC – European Interdisciplinary Society of AI for Cancer Research meeting on May 7 & 8. […]
News
May, 6 2026
Michael Willis, our partner from IHE – The Swedish Institute for Health Economics, spoke last week at the 2026 Swedish […]
News
October, 20 2025
Join the discussion this Saturday, October 18, 2025, at the Hamburg Auditorium – CityCube A, to explore how AI is […]